Is My Fatigue from Sjögren's or Fibromyalgia?
Published: | Updated:
Sjögren's syndrome causes inflammatory fatigue and localized joint pain, while fibromyalgia causes widespread pain and unrefreshing sleep due to central sensitization. Doctors distinguish them using symptom and inflammation scores to ensure you receive the correct treatment.
Key Takeaways
- • Sjögren's fatigue is driven by autoimmune inflammation, whereas fibromyalgia is caused by a hyperexcitable nervous system.
- • A high symptom burden despite low inflammation in your bloodwork often suggests fibromyalgia rather than active Sjögren's.
- • Immunosuppressants and steroids treat active Sjögren's but will not relieve fibromyalgia pain.
- • Tracking whether your pain is localized or widespread can help your rheumatologist make an accurate diagnosis.
If you are living with Primary Sjögren’s Syndrome, it can be incredibly frustrating to figure out whether your daily exhaustion and aching are caused by Sjögren’s itself or by a co-occurring condition like Fibromyalgia. Distinguishing between the two is difficult because the symptoms feel remarkably similar. However, they are driven by two fundamentally different processes in the body: inflammatory fatigue (from Sjögren’s) and central sensitization (from Fibromyalgia) [1][2]. Knowing which condition is causing your symptoms is essential because they require entirely different treatments [3][2].
Inflammatory Fatigue vs. Central Sensitization
To understand the difference, it helps to look at what is happening inside your body:
- Sjögren’s Syndrome (Inflammatory Fatigue and Pain): Sjögren’s is an autoimmune disease where your immune system attacks your own body. This creates systemic (body-wide) inflammation fueled by specific inflammatory proteins [1][4]. The fatigue and localized joint pain you feel from active Sjögren’s are direct results of this inflammatory immune response [5][6].
- Fibromyalgia (Central Sensitization): Fibromyalgia is not an autoimmune disease. Instead, it is characterized by central sensitization [1][2]. This means your central nervous system (your brain and spinal cord) has become physically hyperexcitable. It amplifies pain signals, turning normal sensations into widespread pain, and causes profound, unrefreshing fatigue [2].
Why It Is So Difficult to Tell Them Apart
Fibromyalgia is highly prevalent among patients with Primary Sjögren’s Syndrome [7][8]. Because they frequently coexist, your fatigue and pain might actually be coming from both conditions at the same time [9][8].
The clinical overlap of a triad of symptoms—dryness, severe fatigue, and widespread pain—creates a diagnostic challenge [10][11]. Central sensitization can significantly impact your daily functioning and make your Sjögren’s feel much more severe than your bloodwork might suggest [2].
How Your Rheumatologist Can Tell the Difference
Because there is no single blood test for fibromyalgia, rheumatologists rely on specialized scoring systems to separate your lived experience of symptoms from objective, measurable inflammation. They typically use two scales:
- ESSDAI (EULAR Sjögren’s Syndrome Disease Activity Index): This scale measures objective, systemic inflammatory activity [12][10]. Your doctor calculates this using lab results (like inflammatory markers), directly observing swollen joints, and running tests checking for involvement of major organs like the lungs or kidneys [12][13].
- ESSPRI (EULAR Sjögren’s Syndrome Patient Reported Index): This scale measures your symptom burden [12][10]. It relies on your reporting of dryness, fatigue, and pain [14]. While this relies on your reporting, the pain is very real and stems from physical changes in your nervous system. When suspecting Fibromyalgia, doctors look specifically closely at the pain and fatigue parts of this score.
The “Discordance” Clue: Often, there is a mismatch between these two scores [7][2]. If your ESSPRI score is very high (meaning you feel terrible, with severe pain and fatigue) but your ESSDAI score is low (meaning your bloodwork and organ function show very little active inflammation), this strongly suggests that central sensitization or comorbid fibromyalgia is driving your symptoms [7][15].
Why Accurate Diagnosis Matters for Your Treatment
Correctly identifying the source of your pain and fatigue protects you from unnecessary and potentially harmful treatments.
- Treating Sjögren’s: If your ESSDAI shows active systemic or major organ involvement, doctors may prescribe medications that suppress or modulate the immune system, such as immunosuppressants or corticosteroids [3][2]. However, these are generally not prescribed for standard Sjögren’s fatigue without organ involvement.
- Treating Fibromyalgia: Central sensitization does not respond to immunosuppressants or steroids [2][16]. If your doctor mistakenly assumes your severe, widespread pain is from active Sjögren’s, you might be given strong immune-suppressing drugs or steroids that will not fix your pain but will expose you to significant side effects [2][16][3]. Instead, fibromyalgia requires therapies that calm the central nervous system, such as medications that reduce nerve pain, tailored sleep therapies, and gentle, low-impact movement [3][17].
How You Can Help Your Doctor
To help your rheumatologist calculate your scores accurately, consider keeping a symptom diary between appointments. Note the specific nature of your pain (e.g., “my knees were swollen and hot” versus “my whole body felt tender to the touch”) and rate your daily dryness, fatigue, and pain on a scale of 1 to 10.
Frequently Asked Questions
How can I tell if my pain is from Sjögren's or fibromyalgia?
What is the difference between inflammatory fatigue and fibromyalgia fatigue?
Why does my rheumatologist track ESSDAI and ESSPRI scores?
Will my Sjögren's medications help relieve my fibromyalgia pain?
Questions for Your Doctor
- • Could we review my ESSDAI and ESSPRI scores together so I can understand if my symptoms align with my bloodwork?
- • Do you see signs of active systemic inflammation in my labs that warrant treatment, or does my pain look more like central sensitization?
- • What medications or therapies do you recommend that specifically target central nervous system hyperexcitability rather than inflammation?
- • How can I best track my symptoms between appointments to help you calculate my scores accurately?
Questions for You
- • Does my pain feel localized to specific, hot, and swollen joints, or does it feel like a widespread, all-over body ache and tenderness?
- • Is my fatigue improved even slightly by rest, or do I wake up feeling unrefreshed regardless of how much I sleep?
- • Have I been assuming that a flare-up of pain means my Sjögren's is progressing, without considering that it could be a separate issue like Fibromyalgia?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Renal Disease in Primary Sjögren's Syndrome.
Aiyegbusi O, McGregor L, McGeoch L, et al.
Rheumatology and therapy 2021; (8(1)):63-80 doi:10.1007/s40744-020-00264-x.
PMID: 33367966 - 2
Central sensitization significantly deteriorates functionality and the interpretation of self-reported disease activity in primary Sjögren's syndrome.
Sariyildiz A, Coskun Benlidayi I, Yetişir A, et al.
Clinical rheumatology 2024; (43(6)):1949-1958 doi:10.1007/s10067-024-06981-w.
PMID: 38691249 - 3
Neurologic Manifestations of Primary Sjögren Syndrome.
Margaretten M
Rheumatic diseases clinics of North America 2017; (43(4)):519-529 doi:10.1016/j.rdc.2017.06.002.
PMID: 29061239 - 4
Salivary free light chains and salivary immunoglobulins as potential non-invasive biomarkers in primary Sjögren's syndrome.
Sandhya P, Kabeerdoss J, Christudoss P, et al.
International journal of rheumatic diseases 2022; (25(1)):61-69 doi:10.1111/1756-185X.14242.
PMID: 34791797 - 5
In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome.
Kabeerdoss J, Sandhya P, Kurien BT, et al.
Rheumatology international 2022; (42(3)):545-551 doi:10.1007/s00296-021-04859-7.
PMID: 33861386 - 6
Cardamonin inhibits pro-inflammatory cytokine production and suppresses NO pathway in PBMCs from patients with primary Sjögren's syndrome.
Benchabane S, Belguendouz H, Behairi N, et al.
Immunopharmacology and immunotoxicology 2018; (40(2)):126-133 doi:10.1080/08923973.2017.1418881.
PMID: 29303022 - 7
Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren's syndrome.
Choi BY, Oh HJ, Lee YJ, Song YW
Clinical and experimental rheumatology 2016; (34(2 Suppl 96)):S9-13.
PMID: 26315451 - 8
Higher Risk for Sjögren's Syndrome in Patients With Fibromyalgia: A Nationwide Population-Based Cohort Study.
Gau SY, Leong PY, Lin CL, et al.
Frontiers in immunology 2021; (12()):640618 doi:10.3389/fimmu.2021.640618.
PMID: 33912165 - 9
Sex differences in comorbidities associated with Sjögren's disease.
Bruno KA, Morales-Lara AC, Bittencourt EB, et al.
Frontiers in medicine 2022; (9()):958670 doi:10.3389/fmed.2022.958670.
PMID: 35991633 - 10
Sjögren's syndrome.
André F, Böckle BC
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2022; (20(7)):980-1002 doi:10.1111/ddg.14823.
PMID: 35775593 - 11
Fibromyalgia, Sjogren's & depression: linked?
Loganathan M, Ladani A, Lippmann S
Postgraduate medicine 2020; (132(7)):575-580 doi:10.1080/00325481.2020.1758426.
PMID: 32314938 - 12
Correspondence on 'Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial'.
Wang B, Chen S, Xuan J, et al.
Annals of the rheumatic diseases 2023; (82(3)):e67 doi:10.1136/annrheumdis-2020-219666.
PMID: 33504477 - 13
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
Bowman SJ, Fox R, Dörner T, et al.
Lancet (London, England) 2022; (399(10320)):161-171 doi:10.1016/S0140-6736(21)02251-0.
PMID: 34861168 - 14
Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren's.
Cooper C, Wratten S, Williams-Hall R, et al.
Rheumatology and therapy 2022; (9(6)):1499-1515 doi:10.1007/s40744-022-00487-0.
PMID: 36114443 - 15
Sleep quality in patients with primary Sjögren's syndrome.
Priori R, Minniti A, Antonazzo B, et al.
Clinical and experimental rheumatology 2016; (34(3)):373-9.
PMID: 27087620 - 16
Meta-Analysis of Treatment for Primary Sjögren's Syndrome.
Chu LL, Cui K, Pope JE
Arthritis care & research 2020; (72(7)):1011-1021 doi:10.1002/acr.23917.
PMID: 31058469 - 17
Experience of sleep disruption in primary Sjögren's syndrome: A focus group study.
Hackett KL, Deary V, Deane KH, et al.
The British journal of occupational therapy 2018; (81(4)):218-226 doi:10.1177/0308022617745006.
PMID: 29657352
This page explains the differences between Sjögren's syndrome and fibromyalgia symptoms for educational purposes. Always consult your rheumatologist to accurately diagnose the source of your pain and fatigue.
Stay up to date
Get notified when new research about Primary Sjögren's Syndrome is published.
No spam. Unsubscribe anytime.